Novo Nordisk's CEO is set to confront U.S. Senator Bernie Sanders regarding the high prices of their diabetes and weight loss ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

Novo Nordisk's chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of ...

Did she gain the weight back? Here's what she says, plus more mindful takeaways for the reported 15 million Americans who ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic ...

Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.